DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
CALCIUM PHOSPHATE, TRIBASIC
2
Small molecule
Investigational
Unknown
Unknown
Dental Caries
Unknown
CALCIUM PHOSPHATE, TRIBASIC
×
Maximum Phase:
2
First Approval:
None
UNII:
91D9GV0Z28
Molecule Type:
Small molecule
Molecular Formula:
Ca3O8P2
Molecular Weight:
310.17
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TAURINE
2
Small molecule
Investigational
Unknown
Unknown
Homocystinuria; Multiple Sclerosis; Bipolar Disorder; Diabetes Mellitus, Type 2; Mental Disorders; Stomach Neoplasms; Hypertension; Xerostomia
Unknown
TAURINE
×
Maximum Phase:
2
First Approval:
None
UNII:
1EQV5MLY3D
Molecule Type:
Small molecule
Molecular Formula:
C2H7NO3S
Molecular Weight:
125.15
AlogP:
-1.17
PSA:
80.39
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PLOVAMER ACETATE
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis, Relapsing-Remitting
HLA class II histocompatibility antigen, DRB1-15 beta chain modulator
PLOVAMER ACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
5511VZ6NRQ
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FUCOXANTHIN
2
Small molecule
Investigational
Unknown
Unknown
Metabolic Syndrome
Unknown
FUCOXANTHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
06O0TC0VSM
Molecule Type:
Small molecule
Molecular Formula:
C40H56O6
Molecular Weight:
632.88
AlogP:
8.14
PSA:
96.36
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TROXACITABINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia
DNA polymerase (alpha/delta/epsilon) inhibitor
TROXACITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
60KQZ0388Y
Molecule Type:
Small molecule
Molecular Formula:
C8H11N3O4
Molecular Weight:
213.19
AlogP:
-1.31
PSA:
99.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
VX-702
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
MAP kinase p38 alpha inhibitor
VX-702
×
Maximum Phase:
2
First Approval:
None
UNII:
527E7SK68P
Molecule Type:
Small molecule
Molecular Formula:
C19H12F4N4O2
Molecular Weight:
404.32
AlogP:
3.62
PSA:
102.31
HBD:
2.0
HBA:
#RotB:
4.0
Source:
MSDC-0160
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MSDC-0160
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
T-817
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
T-817
×
Maximum Phase:
2
First Approval:
None
UNII:
QY49O94S2W
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO2S
Molecular Weight:
291.42
AlogP:
2.53
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
7.0
Source:
AMELUBANT
2
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis; Arthritis, Rheumatoid; Asthma; Pulmonary Disease, Chronic Obstructive
Leukotriene B4 receptor 1 antagonist
AMELUBANT
×
Maximum Phase:
2
First Approval:
None
UNII:
E0018IF0K4
Molecule Type:
Small molecule
Molecular Formula:
C33H34N2O5
Molecular Weight:
538.64
AlogP:
6.95
PSA:
100.87
HBD:
3.0
HBA:
#RotB:
10.0
Source:
GRC-17536
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies
Transient receptor potential cation channel subfamily A member 1 antagonist
GRC-17536
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
JNJ-37822681
2
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Dopamine D2 receptor antagonist
JNJ-37822681
×
Maximum Phase:
2
First Approval:
None
UNII:
GJB2URS7NJ
Molecule Type:
Small molecule
Molecular Formula:
C17H17F5N4
Molecular Weight:
372.34
AlogP:
3.85
PSA:
41.05
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NEVANIMIBE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Adrenal Hyperplasia, Congenital; Cushing Syndrome
Unknown
NEVANIMIBE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
TK694ZFS57
Molecule Type:
Small molecule
Molecular Formula:
C27H40ClN3O
Molecular Weight:
458.09
AlogP:
6.63
PSA:
44.37
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PELITREXOL
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Colorectal Neoplasms; Lung Neoplasms
GAR transformylase inhibitor
PELITREXOL
×
Maximum Phase:
2
First Approval:
None
UNII:
DHT6E8M4KP
Molecule Type:
Small molecule
Molecular Formula:
C20H25N5O6S
Molecular Weight:
463.52
AlogP:
0.99
PSA:
187.5
HBD:
6.0
HBA:
#RotB:
9.0
Source:
BMS-986142
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis; Arthritis, Rheumatoid
Tyrosine-protein kinase BTK inhibitor
BMS-986142
×
Maximum Phase:
2
First Approval:
None
UNII:
PJX9GH268R
Molecule Type:
Small molecule
Molecular Formula:
C32H30F2N4O4
Molecular Weight:
572.61
AlogP:
4.4
PSA:
123.11
HBD:
3.0
HBA:
#RotB:
4.0
Source:
AMG-208
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms, Castration-Resistant
Hepatocyte growth factor receptor inhibitor
AMG-208
×
Maximum Phase:
2
First Approval:
None
UNII:
Y2SR66P7VM
Molecule Type:
Small molecule
Molecular Formula:
C22H17N5O2
Molecular Weight:
383.41
AlogP:
3.93
PSA:
74.43
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ITACITINIB ADIPATE
2
Small molecule
Investigational
Unknown
Unknown
Bronchiolitis Obliterans
Unknown
ITACITINIB ADIPATE
×
Maximum Phase:
2
First Approval:
None
UNII:
XZG407XE0Y
Molecule Type:
Small molecule
Molecular Formula:
C32H33F4N9O5
Molecular Weight:
699.67
AlogP:
3.6
PSA:
119.62
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CAPESEROD
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Serotonin 4 (5-HT4) receptor partial agonist
CAPESEROD
×
Maximum Phase:
2
First Approval:
None
UNII:
8163770L8P
Molecule Type:
Small molecule
Molecular Formula:
C23H25ClN4O4
Molecular Weight:
456.93
AlogP:
3.39
PSA:
95.75
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ALBACONAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Tinea Pedis; Onychomycosis; Vulvovaginitis
Lanosterol 14-alpha demethylase inhibitor
ALBACONAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
YDW24Y8IAB
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClF2N5O2
Molecular Weight:
431.83
AlogP:
3.07
PSA:
85.83
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FUNAPIDE
2
Small molecule
Investigational
Unknown
Unknown
Erythromelalgia; Neuralgia, Postherpetic; Osteoarthritis, Knee
Unknown
FUNAPIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
A5595LHJ2L
Molecule Type:
Small molecule
Molecular Formula:
C22H14F3NO5
Molecular Weight:
429.35
AlogP:
4.25
PSA:
61.14
HBD:
0.0
HBA:
#RotB:
2.0
Source:
BIIB021
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Neoplasms; Breast Neoplasms; Gastrointestinal Stromal Tumors
Heat shock protein HSP90 inhibitor
BIIB021
×
Maximum Phase:
2
First Approval:
None
UNII:
851B9FQ7Q0
Molecule Type:
Small molecule
Molecular Formula:
C14H15ClN6O
Molecular Weight:
318.77
AlogP:
2.13
PSA:
91.74
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MILCICLIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Thymoma
Cyclin-dependent kinase 1 inhibitor
MILCICLIB
×
Maximum Phase:
2
First Approval:
None
UNII:
688000M8S8
Molecule Type:
Small molecule
Molecular Formula:
C25H32N8O
Molecular Weight:
460.59
AlogP:
2.57
PSA:
91.21
HBD:
2.0
HBA:
#RotB:
4.0
Source:
MK-8777
2
Small molecule
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity; Depressive Disorder
Glutamate receptor ionotropic AMPA positive allosteric modulator
MK-8777
×
Maximum Phase:
2
First Approval:
None
UNII:
0H1IDR8Z4F
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RAVIDASVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic; Virus Diseases
Nonstructural protein 5A inhibitor
RAVIDASVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
AL3G001BI8
Molecule Type:
Small molecule
Molecular Formula:
C42H50N8O6
Molecular Weight:
762.91
AlogP:
6.86
PSA:
174.64
HBD:
4.0
HBA:
#RotB:
10.0
Source:
VIPADENANT
2
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Adenosine A2a receptor antagonist
VIPADENANT
×
Maximum Phase:
2
First Approval:
None
UNII:
LDR3USH1NJ
Molecule Type:
Small molecule
Molecular Formula:
C16H15N7O
Molecular Weight:
321.34
AlogP:
2.0
PSA:
121.67
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CDC-801
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes
Unknown
CDC-801
×
Maximum Phase:
2
First Approval:
None
UNII:
95HB56U8P8
Molecule Type:
Small molecule
Molecular Formula:
C23H24N2O5
Molecular Weight:
408.45
AlogP:
3.23
PSA:
98.93
HBD:
1.0
HBA:
#RotB:
7.0
Source:
AXELOPRAN
2
Small molecule
Investigational
Unknown
Unknown
Constipation
Mu opioid receptor antagonist
AXELOPRAN
×
Maximum Phase:
2
First Approval:
None
UNII:
85U7ROB149
Molecule Type:
Small molecule
Molecular Formula:
C26H39N3O4
Molecular Weight:
457.62
AlogP:
2.26
PSA:
107.1
HBD:
3.0
HBA:
#RotB:
9.0
Source:
FIMEPINOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Large B-Cell, Diffuse; Lymphoma; Pituitary ACTH Hypersecretion; Thyroid Neoplasms
Histone deacetylase inhibitor
FIMEPINOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
3S9RX35S5X
Molecule Type:
Small molecule
Molecular Formula:
C23H24N8O4S
Molecular Weight:
508.56
AlogP:
2.14
PSA:
138.72
HBD:
2.0
HBA:
#RotB:
7.0
Source:
FOSRAVUCONAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Mycetoma
Cytochrome P450 51 inhibitor
FOSRAVUCONAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
L4Q6O5430L
Molecule Type:
Small molecule
Molecular Formula:
C23H20F2N5O5PS
Molecular Weight:
547.48
AlogP:
4.33
PSA:
143.38
HBD:
2.0
HBA:
#RotB:
10.0
Source:
NIMUSTINE
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms
DNA disrupting agent
NIMUSTINE
×
Maximum Phase:
2
First Approval:
None
UNII:
0S726V972K
Molecule Type:
Small molecule
Molecular Formula:
C9H13ClN6O2
Molecular Weight:
272.7
AlogP:
0.8
PSA:
113.57
HBD:
2.0
HBA:
#RotB:
5.0
Source:
URSOLIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Cholangitis, Sclerosing; Prostatic Neoplasms, Castration-Resistant; Metabolic Syndrome
Unknown
URSOLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
P3M2575F3F
Molecule Type:
Small molecule
Molecular Formula:
C30H48O3
Molecular Weight:
456.71
AlogP:
7.09
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
1.0
Source:
THYMOQUINONE
2
Small molecule
Investigational
Unknown
Unknown
Immunologic Deficiency Syndromes; Severe Acute Respiratory Syndrome
Unknown
THYMOQUINONE
×
Maximum Phase:
2
First Approval:
None
UNII:
O60IE26NUF
Molecule Type:
Small molecule
Molecular Formula:
C10H12O2
Molecular Weight:
164.2
AlogP:
1.67
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
1.0
Source:
NALTALIMIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Mu opioid receptor partial agonist
NALTALIMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
PUO0LMS4NX
Molecule Type:
Small molecule
Molecular Formula:
C28H28N2O5
Molecular Weight:
472.54
AlogP:
2.62
PSA:
90.31
HBD:
2.0
HBA:
#RotB:
3.0
Source:
OTAPLIMASTAT
2
Small molecule
Investigational
Unknown
Unknown
Ischemic Stroke
Unknown
OTAPLIMASTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
UYE03B60KA
Molecule Type:
Small molecule
Molecular Formula:
C28H34N6O5
Molecular Weight:
534.62
AlogP:
1.39
PSA:
142.06
HBD:
3.0
HBA:
#RotB:
13.0
Source:
MITOQUINONE MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Aging; Cardiomyopathy, Dilated; Colitis, Ulcerative; Hepatitis C, Chronic; Non-alcoholic Fatty Liver Disease; Parkinson Disease
Unknown
MITOQUINONE MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
6E01CG547T
Molecule Type:
Small molecule
Molecular Formula:
C38H47O7PS
Molecular Weight:
678.83
AlogP:
7.46
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
16.0
Source:
ABT-126
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
ABT-126
×
Maximum Phase:
2
First Approval:
None
UNII:
WX8LOM674D
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3OS
Molecular Weight:
313.43
AlogP:
2.92
PSA:
38.25
HBD:
0.0
HBA:
#RotB:
3.0
Source:
1
2
…
128
129
130
131
132
133
134
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA